Anastacia L. Wall, PA-C 8092 E 49th Pl Denver, CO 80238 [email protected] (206) 351-3331 cell (303)266-0774 pager EXPERIENCE September 2013 – present Instructor/Physician Assistant University of Colorado-Denver Dr. Tim Vollmer, MD Rocky Mountain Multiple Sclerosis Center University of Colorado Hospital-- Anschutz Outpatient Pavilion 1635 Aurora Court, Suite 5210 Aurora, CO 80045 Telephone: (720) 848-2080 Fax: (720) 848-0640 February 2012 – August 2013 Neurology Physician Assistant Swedish Neuroscience Specialists, Swedish Medical Group (SMG) Dr. Lily Jung Henson, MD 751 NE Blakely Dr, Suite 4020 Issaquah, WA 98029 Office: (425) 313-7070 January 2008 – February 2012 Neurohospitalist Physician Assistant Swedish Neuroscience Institute (SNI) Joint Commission Certified Comprehensive Stroke Center, Telestroke Program Dr. Bill Likosky, MD, Stroke Program Medical Director Swedish Medical Center (SMC) 500 17th Ave Seattle, WA 98122 Office: (206) 320-2208 January 2000 – July 2005 Director of Clinical Education/Clinical Specialist Swedish Sleep Medicine Associates Dr. Ralph Pascualy, Medical Director 801 Broadway, Ste 701 Seattle WA 98122 Office: (206) 386-4744 2001 - 2005 Associate Professor Highline Community College, Polysomnography Technology Program Post Office Box 98000 Des Moines, Washington 98198-9800 Office: (206) 592-3677 LICENSURES/CERTIFICATIONS CITI Program Certification for Clinical Investigators EDSS Certified Colorado State License: PA 3785 Washington State License: PA10005372 DEA #MW1730868 NCCPA: Certified Physician Assistant, #1079998 1 Anastacia L. Wall, PA-C 8092 E 49th Pl Denver, CO 80238 [email protected] (206) 351-3331 cell (303)266-0774 pager RESEARCH ONO-4641POU007 (EMR 200559-002): A safety and efficacy extension study of ONO-4641 in patients with relapsing remitting multiple sclerosis CFTY720D2312: A 12-month, randomized, rater- and dose-blinded study to compare the efficacy and safety of fingolimod 0.25 mg and 0.5 mg administered orally once daily with glatiramer acetate 20 mg administered subcutaneously once daily in patients with relapsing-remitting multiple sclerosis CBAF312A2304: A multicenter, randomized, double-blind, parallel-group, placebo-controlled variable treatment duration study evaluating the efficacy and safety of Siponimod (BAF312) in patients with secondary progressive multiple sclerosis LAQ-MS-305: A multinational, multicenter, randomized, double-blind, parallel-group, placebocontrolled study followed by an active treatment period, to evaluate the efficacy, safety and tolerability of two doses of oral administration of laquinimod (0.6 mg/day or 1.2 mg/day) in subjects with relapsing remitting multiple sclerosis (RRMS) MS-LAQ-302E: Study Title: A multinational, multicenter, open-label, single-assignment extension of the MS-LAQ-302 (BRAVO) study, to evaluate the long-term safety, tolerability and effect on disease course of daily oral laquinimod 0.6 mg in subjects with relapsing multiple sclerosis IM22-MS-1004: A Double-Blind, Placebo-Controlled, Single Ascending Intravenous Infusion Study of rHIgM22 in Patients with Multiple Sclerosis Gateway II: A Phase II, Double Blinded, Placebo Controlled, Randomized Study Comparing Rituximab Induction Therapy Followed by Glatiramer Acetate Therapy to Glatiramer Acetate Monotherapy in Patients with Relapsing Forms of Multiple Sclerosis Current sub-investigator in Opexa study Abili-T 2012-00, outsite #004, A novel T-cell immunotherapy that has been granted Fast Track designation by the U.S. FDA for the Secondary Progressive MS (SP-MS) indication Erica Tomas, Anastacia Wall, Amer Malik, and Lily Jung-Henson. IRIS in a Multiple Sclerosis Patient after Discontinuation of Natalizumab and Newly Started on Fingolimod. (P04.133) Neurology April 22, 2012 78:P04.133 Poster Presentation P04.133 American Academy of Neurology Annual Conference, New Orleans, April 2012 DEFUSE 2 trial: To predict which patients will benefit from endovascular therapy for acute stroke using MRI perfusion/diffusion technology. 2011- 2012 DIAS 4 trial: To evaluate the effectiveness of desmoteplase vs. placebo in terms of favorable outcome at Day 90 in subjects with acute ischemic stroke 2011-2012 2 Anastacia L. Wall, PA-C 8092 E 49th Pl Denver, CO 80238 [email protected] (206) 351-3331 cell (303)266-0774 pager EDUCATION 2005 - 2007 Bachelor’s of Clinical Health Service MEDEX Northwest Physician Assistant Program University of Washington, School of Medicine 4311 11th Ave NE, Ste 200 Seattle WA 98105 (206) 616-4001 2002 - 2003 Training Specialist Certificate University of Washington Seattle WA 98105 (206) 897-8939 1997 – 2000 Bachelor of Arts (Phi Beta Kappa, cum laude) University of Washington Box 355850 Seattle WA 98195-5850 (206) 543-2100 PROFESSIONAL MEMBERSHIPS Consortium of Multiple Sclerosis Centers 2013 American Academy of Neurology 2007-present Washington State Neurological Society 2009-present Washington Academy of Physician Assistants, 2005 - Present American Academy of Physician Assistants, 2005 – Present. --Student HOD representative 2005-2006 COMMITTEES/PRIVILEGES Hospital privileges at University of Colorado Hospital Sept 2013-present Swedish Medical Group, Advanced Practice Clinician Council, Chairperson, April to August 2013 SMG, Physician Executive Committee, Human Resources Committee, April to August 2013 SNI Neurology Advanced Practice Committee, Chairperson February to August 2013 Planning committee for Acute Care Neurology and Neurosurgery conference, June 2012 SNI Advanced Practice Clinician leadership committee 2010-2012 Telestroke Planning committee 2010-2011 Hospital privileges at Swedish Medical Center, 2008-2013 PUBLIC SPEAKING ENGAGEMENTS American Heart Association Champion Swedish Medical Center Community Events--Topic: Stroke Prevention SNI Grand Rounds SNI Case conference 3 Anastacia L. Wall, PA-C 8092 E 49th Pl Denver, CO 80238 [email protected] (206) 351-3331 cell (303)266-0774 pager RECENT PROFESSIONAL VOLUNTEERISM National Multiple Sclerosis Society Walk MS, Swedish S’myelin Striders, Co-captain, 2013 National Multiple Sclerosis Society Bike MS--Mount Vernon 2011, 2012 National Multiple Sclerosis Society Walk MS--Seattle 2012 National Parkinson Foundation: Hope Through Research, 2012 Hands of Hope, Medical mission to Guatemala April 2007 HONORS AND AWARDS Richard H Peterson Commitment to Excellence Award 2008 University of Washington, Phi Beta Kappa and departmental honors, 1999 Mary Gates Leadership Endowment, 1998-1999 S. Sterling Munro Public Service Fellowship, 1998-1999 Anastacia Wall, PA-C is on the clinical and research team at Rocky Mountain Multiple Sclerosis Center at the Anschutz Medical Center. She works in partnership with Dr. Vollmer to provide comprehensive care for their patients. Anastacia completed her undergraduate and professional training at the University of Washington MEDEX NW program in Seattle. Her first position was as a Neuro-Hospitalist at Swedish Neuroscience Institute (SNI); a Comprehensive Stroke Center. She then transitioned to outpatient Neurology, seeing patients with a focus in Neuro-Immunology. While in Seattle, she pioneered the development of and served as chairperson for both the Advanced Practice Clinician Executive Council and the SNI Neuroscience Advanced Practice Clinician Committee. She enjoys heading to the mountains with her husband, two children, and Chesapeake Bay Retrievers. 4
© Copyright 2024 ExpyDoc
